[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 1992

The Impact of Human T-Lymphotrophic Virus Type I/II Infection on the Prognosis of Sexually Acquired Cases of Acquired Immunodeficiency Syndrome

Author Affiliations

From the "Alexander Von Humboldt" Institute of Tropical Medicine, Cayetano Heredia Peruvian University (Drs Gotuzzo and Sanchez), US Naval Medical Research Institute Detachment (Drs Escamilla and Wignall and Mr Phillips), and "Edgardo Rebagliati Martins" Hospital and National Program for the Control of AIDS, Health Ministry (Dr Antigoni), Lima, Peru.

Arch Intern Med. 1992;152(7):1429-1432. doi:10.1001/archinte.1992.00400190063012

Twenty (18%) of 111 Peruvian men with sexually acquired human immunodeficiency virus infection were found also to be infected with human T-lymphotrophic virus type I or II in a retrospective study. At the time of data evaluation, 75 patients had reached Centers for Disease Control stage IV (clinical acquired immunodeficiency syndrome) and had not received antiviral medication; mortality in this group was 63.3% (38/60) among patients infected with human immunodeficiency virus alone and 80% (12/15) in the dually infected group. Of the 50 patients who had died, survival time from onset of stage IV to death was shorter in the dually infected group (5.02±3.27 months) than in those with human immunodeficiency virus infection alone (10.07±4.42 months). In Peru, sexually acquired human immunodeficiency virus infection in men is often accompanied by human T-lymphotrophic virus type I/II infection, and dual retrovirus infection is associated with a shorter survival after onset of clinical acquired immunodeficiency syndrome.

(Arch Intern Med. 1992;152:1429-1432)